NIAID Pandemic Preparedness Plan   [open pdf - 1MB]

From the Introduction: "The emergence and re-emergence of infectious diseases continues to threaten the health of Americans and people worldwide. In the past two decades NIAID [National Institute of Allergy and Infectious Diseases] has mounted major research responses and developed effective countermeasures to emerging infectious diseases including those caused by SARS-CoV-1 [severe acute respiratory syndrome coronavirus 1], the 2009 H1N1 influenza virus, Middle East Respiratory Syndrome coronavirus (MERS-CoV), Ebola virus, Zika virus, and most recently SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2]. The ongoing 2020 global pandemic caused by SARS-CoV-2 further has underscored the continual threat of newly emerging and re-emerging pathogens and the critical value of research in pandemic preparedness efforts. To prepare for future public health emergencies caused by infectious diseases, NIAID has developed a Pandemic Preparedness Plan that leverages its broad research portfolio, long-standing expertise in product development, capacity to engage both domestic and international partners, and flexible infrastructure. While it is recognized that pathogens other than viruses could lead to public health emergencies, the NIAID Pandemic Preparedness Plan focuses on viruses that could cause epidemics or pandemics."

Public Domain
Retrieved From:
National Institute of Allergy and Infectious Diseases: https://www.niaid.nih.gov/
Media Type:
Help with citations